Arax Advisory Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83M | Buy |
326,790
+285,409
| +690% | +$66.5M | 0.55% | 28 |
|
|
2026
Q1 | $10.1M | Buy |
41,381
+9,065
| +28% | +$2.11M | 0.29% | 76 |
|
|
2025
Q4 | $6.69M | Sell |
32,316
-107,418
| -77% | -$21.2M | 0.19% | 101 |
|
|
2025
Q3 | $25.9M | Buy |
139,734
+118,906
| +571% | +$20.4M | 0.37% | 33 |
|
|
2025
Q2 | $3.69M | Buy |
20,828
+4,060
| +24% | +$624K | 0.17% | 101 |
|
|
2025
Q1 | $2.78M | Sell |
16,768
-393
| -2% | -$61.5K | 0.18% | 90 |
|
|
2024
Q4 | $2.48M | Buy |
17,161
+1,682
| +11% | +$261K | 0.16% | 95 |
|
|
2024
Q3 | $2.51M | Sell |
15,479
-142
| -0.9% | -$22.6K | 0.22% | 60 |
|
|
2024
Q2 | $2.28M | Buy |
15,621
+356
| +2% | +$52.9K | 0.22% | 64 |
|
|
2024
Q1 | $2.41M | Sell |
15,265
-1,779
| -10% | -$283K | 0.25% | 57 |
|
|
2023
Q4 | $2.67M | Sell |
17,044
-246
| -1% | -$37.7K | 0.3% | 53 |
|
|
2023
Q3 | $2.69M | Sell |
17,290
-57
| -0.3% | -$9.4K | 0.34% | 53 |
|
|
2023
Q2 | $2.87M | Buy |
17,347
+73
| +0.4% | +$11.8K | 0.37% | 46 |
|
|
2023
Q1 | $2.68M | Sell |
17,274
-74
| -0.4% | -$11.9K | 0.35% | 44 |
|
|
2022
Q4 | $3.06M | Sell |
17,348
-104
| -0.6% | -$18K | 0.42% | 40 |
|
|
2022
Q3 | $2.85M | Buy |
17,452
+977
| +6% | +$165K | 0.45% | 36 |
|
|
2022
Q2 | $2.92M | Buy |
16,475
+534
| +3% | +$95.1K | 0.44% | 38 |
|
|
2022
Q1 | $2.83M | Buy |
15,941
+10
| +0.1% | +$1.7K | 0.38% | 43 |
|
|
2021
Q4 | $2.73M | Buy |
15,931
+44
| +0.3% | +$7.2K | 0.35% | 44 |
|
|
2021
Q3 | $2.57M | Buy |
15,887
+237
| +2% | +$40.4K | 0.35% | 44 |
|
|
2021
Q2 | $2.58M | Buy |
+15,650
| New | +$2.59M | 0.35% | 48 |
|
|
2020
Q4 | $2.44M | Hold |
15,516
| – | – | 0.36% | 42 |
|
|
2020
Q3 | $2.31M | Sell |
15,516
-675
| -4% | -$99.9K | 0.39% | 42 |
|
|
2020
Q2 | $2.28M | Sell |
16,191
-768
| -5% | -$112K | 0.41% | 41 |
|
|
2020
Q1 | $2.22M | Sell |
16,959
-552
| -3% | -$78.3K | 0.51% | 35 |
|
|
2019
Q4 | $2.55M | Buy |
17,511
+59
| +0.3% | +$8K | 0.73% | 23 |
|
|
2019
Q3 | $2.26M | Buy |
17,452
+79
| +0.5% | +$10.4K | 0.68% | 24 |
|
|
2019
Q2 | $2.42M | Buy |
+17,373
| New | +$2.4M | 0.81% | 22 |
|
|
2018
Q4 | $2.42M | Buy |
18,757
+1,596
| +9% | +$223K | 0.96% | 21 |
|
|
2018
Q3 | $2.37M | Sell |
17,161
-7,551
| -31% | -$1M | 0.96% | 15 |
|
|
2018
Q2 | $3M | Buy |
24,712
+10,272
| +71% | +$1.28M | 1.32% | 15 |
|
|
2018
Q1 | $1.85M | Sell |
14,440
-1,146
| -7% | -$155K | 0.96% | 17 |
|
|
2017
Q4 | $2.18M | Buy |
15,586
+7,623
| +96% | +$1.06M | 0.94% | 16 |
|
|
2017
Q3 | $1.03M | Sell |
7,963
-72
| -0.9% | -$9.54K | 0.5% | 20 |
|
|
2017
Q2 | $1.06M | Buy |
8,035
+872
| +12% | +$111K | 0.51% | 22 |
|
|
2017
Q1 | $892K | Buy |
7,163
+640
| +10% | +$76.5K | 0.43% | 20 |
|
|
2016
Q4 | $752K | Buy |
+6,523
| New | +$753K | 0.38% | 23 |
|
Other funds holding JNJ
Arax Advisory Partners's JNJ Position: Q2 2026 in Review
Arax Advisory Partners increased its Johnson & Johnson (JNJ) stake by 690% in Q2 2026, buying an estimated $66.5M and bringing the position to 326,790 shares worth $83M. The position accounts for 0.55% of the portfolio, ranked #28.
Arax Advisory Partners first reported a position in JNJ in Q4 2016 and has held it in 37 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Arax Advisory Partners held 326,790 shares of Johnson & Johnson worth $83M as of Q2 2026.
- Arax Advisory Partners bought 285,409 Johnson & Johnson shares in Q2 2026, an estimated $66.5M.
- Johnson & Johnson made up 0.55% of Arax Advisory Partners's portfolio in Q2 2026, its #28 holding.
- Arax Advisory Partners first reported a position in Johnson & Johnson in Q4 2016 and has held it in 37 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.